Distinct modulation of alkaline phosphatase isoenzymes by 17β-estradiol and xanthohumol in breast cancer MCF-7 cells

Clinical Biochemistry

Volumn 40, Issue 3-4, 2007, Pages 268-273

  Guerreiro, Susana ^a   Monteiro, Rosário ^a   Martins, Maria João ^a   Calhau, Conceição ^a   Azevedo, Isabel ^a   Soares, Raquel ^a  

^a University of Porto   (Portugal)

Author keywords

17 estradiol; Alkaline phosphatase; Breast cancer; Flavonoids; Xanthohumol

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ALKALINE PHOSPHATASE; ESTRADIOL; ISOENZYME; XANTHOHUMOL;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DRUG ACTIVITY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; NICK END LABELING; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPECTROPHOTOMETRY; WESTERN BLOTTING;

ALKALINE PHOSPHATASE; APOPTOSIS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; ESTRADIOL; ESTROGEN ANTAGONISTS; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FEMALE; HUMANS; ISOENZYMES; PROPIOPHENONES; RNA, MESSENGER;

EID: 33846226681     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2006.09.012     Document Type: Article

References (32)

1. Yager J.D., and Davidson N.E. Estrogen carcinogenesis in breast cancer. N. Engl. J. Med. 354 3 (2006) 270-282
2. Soares R., Guo S., Gartner F., Schmitt F.C., and Russo J. 17 beta-estradiol-mediated vessel assembly and stabilization in tumor angiogenesis requires TGF beta and EGFR crosstalk. Angiogenesis 6 4 (2003) 271-281
3. Komoda T., Koyama I., Nagata A., et al. Ontogenic and phylogenic studies of intestinal, hepatic, and placental alkaline phosphatases. Evidence that intestinal alkaline phosphatase is a late evolutionary development. Gastroenterology 91 2 (1986) 277-286
4. Kim S.K., Lee M.H., and Rhee M.H. Studies on the effects of biomedicinal agents on serum concentration of Ca2+, P and ALP activity in osteoporosis-induced rats. J. Vet. Sci. 4 2 (2003) 151-154
5. Le Guevel R., and Pakdel F. Assessment of oestrogenic potency of chemicals used as growth promoter by in-vitro methods. Hum. Reprod. 16 5 (2001) 1030-1036
6. Littlefield B.A., Gurpide E., Markiewicz L., McKinley B., and Hochberg R.B. A simple and sensitive microtiter plate estrogen bioassay based on stimulation of alkaline phosphatase in Ishikawa cells: estrogenic action of delta 5 adrenal steroids. Endocrinology 127 6 (1990) 2757-2762
7. Calhau C., Martel F., Soares-da-Silva P., Hipolito-Reis C., and Azevedo I. Regulation of [(3)H]MPP(+) transport by phosphorylation/dephosphorylation pathways in RBE4 cells: role of ecto-alkaline phosphatase. Naunyn-Schmiedeberg's Arch. Pharmacol. 365 5 (2002) 349-356
8. Van Hoof V.O., and De Broe M.E. Interpretation and clinical significance of alkaline phosphatase isoenzyme patterns. Crit. Rev. Clin. Lab. Sci. 31 3 (1994) 197-293
9. Chang T.C., Wang J.K., Hung M.W., et al. Regulation of the expression of alkaline phosphatase in a human breast-cancer cell line. Biochem. J. 303 Pt 1 (1994) 199-205
10. Hui M., Hu M., and Tenenbaum H.C. Changes in cell adhesion and cell proliferation are associated with expression of tissue non-specific alkaline phosphatase. Cell Tissue Res. 274 3 (1993) 429-437
11. Higashino K., Muratani K., Hada T., et al. Purification and some properties of the fast migrating alkaline phosphatase in FL-amnion cells (the Kasahara isoenzyme) and its cDNA cloning. Clin. Chim. Acta 186 2 (1990) 151-164
12. Millan J.L., and Fishman W.H. Biology of human alkaline phosphatases with special reference to cancer. Crit. Rev. Clin. Lab. Sci. 32 1 (1995) 1-39
13. Albert J.L., Sundstrom S.A., and Lyttle C.R. Estrogen regulation of placental alkaline phosphatase gene expression in a human endometrial adenocarcinoma cell line. Cancer Res. 50 11 (1990) 3306-3310
14. Nilsson S., Makela S., Treuter E., et al. Mechanisms of estrogen action. Physiol. Rev. 81 4 (2001) 1535-1565
15. Gerhäuser C., Alt A., Heiss E., et al. Cancer chemopreventive activity of Xanthohumol, a natural product derived from hop. Mol. Cancer Ther. 1 11 (2002) 959-969
16. Miranda C.L., Stevens J.F., Helmrich A., et al. Antiproliferative and cytotoxic effects of prenylated flavonoids from hops (Humulus lupulus) in human cancer cell lines. Food Chem. Toxicol. 37 4 (1999) 271-285
17. F. Zhao, H. Nozawa, A. Daikonnya, K. Kondo, S. Kitanaka, Inhibitors of nitric oxide.
18. Soares R., Balogh G., Guo S., et al. Evidence for the notch signaling pathway on the role of estrogen in angiogenesis. Mol. Endocrinol. 18 9 (2004) 2333-2343
19. Soares R., Guo S., Russo J., and Schmitt F.C. Role of the estrogen antagonist ICI 182,780 in vessel assembly and apoptosis of endothelial cells. Ultrastruct. Pathol. 27 1 (2003) 33-39
20. Pinheiro-Silva S., Calhau C., and Azevedo I. Phenolic compounds in the control of breast cancer cell growth. FASEB J. 18 (2004) 592-594
21. Henthorn P.S., Raducha M., Edwards Y.H., et al. Nucleotide and amino acid sequences of human intestinal alkaline phosphatase: close homology to placental alkaline phosphatase. Proc. Natl. Acad. Sci. U. S. A. 84 5 (1987) 1234-1238
22. Weiss M.J., Henthorn P.S., Lafferty M.A., et al. Isolation and characterization of a cDNA encoding a human liver/bone/kidney-type alkaline phosphatase. Proc. Natl. Acad. Sci. U. S. A. 83 (1986) 7182-7286
23. Jiang W.G., Davies G., and Fodstad O. Com-1/P8 in oestrogen regulated growth of breast cancer cells, the ER-beta connection. Biochem. Biophys. Res. Commun. 330 1 (2005) 253-262
24. Tso J.Y., Sun X.H., Kao T.H., Reece K.S., and Wu R. Isolation and characterization of rat and human glyceraldehyde-3-phosphate dehydrogenase cDNAs: genomic complexity and molecular evolution of the gene. Nucleic. Acids Res. 13 7 (1985) 2485-2502
25. Tsai L.C., Hung M.W., Chen Y.H., et al. Expression and regulation of alkaline phosphatases in human breast cancer MCF-7 cells. Eur. J. Biochem. 267 5 (2000) 1330-1339
26. Waters K.M., Rickard D.J., Riggs B.L., et al. Estrogen regulation of human osteoblast function is determined by the stage of differentiation and the estrogen receptor isoform. J. Cell. Biochem. 83 3 (2001) 448-462
27. Hall J.M., Couse J.F., and Korach K.S. The multifaceted mechanisms of estradiol and estrogen receptor signaling. J. Biol. Chem. 276 40 (2001) 36869-36872
28. Migliaccio A., Di Domenico M., Castoria G., et al. Tyrosine kinase/p21ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells. EMBO J. 15 6 (1996) 1292-1300
29. Kushner P.J., Agard D.A., Greene G.L., et al. Estrogen receptor pathways to AP-1. J. Steroid Biochem. Mol. Biol. 74 5 (2000) 311-317
30. Peverali F.A., Basdra E.K., and Papavassiliou A.G. Stretch-mediated activation of selective MAPK subtypes and potentiation of AP-1 binding in human osteoblastic cells. Mol. Med. 7 1 (2001) 68-78
31. Kiss A.L., Turi A., Mullner N., et al. Oestrogen-mediated tyrosine phosphorylation of caveolin-1 and its effect on the oestrogen receptor localisation: an in vivo study. Mol. Cell. Endocrinol. 245 1-2 (2005) 128-137
32. Hui M., Li S.Q., Holmyard D., and Cheng P. Stable transfection of nonosteogenic cell lines with tissue nonspecific alkaline phophatase enhances mineral deposition both in the presence and the absence of beta-glycerophosphate: possible role for alkaline phosphatase in pathological mineralization. Calcif. Tissue Int. 60 (1984) 467-472